Intellistem

San Francisco, United States

Intellistem develops innovative cellular immune cancer treatments.

$1.2M raised

Apr 2024

Seed

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Intellistem

How much funding has Intellistem raised?

Intellistem has raised $1.2M in total funding. The most recent round was Seed. The last funding was announced in April 2024.

Where is Intellistem headquartered?

Intellistem is headquartered in San Francisco, United States.

What does Intellistem do?

Intellistem develops innovative cellular immune cancer treatments.

What stage is Intellistem at?

Intellistem is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 16, 2024.

MLA

"Intellistem — Funding & Investors." VCBacked, April 16, 2024, https://www.vcbacked.co/company/intellistem. Accessed July 9, 2026.

APA

VCBacked. (2024). Intellistem — Funding & Investors. Retrieved July 9, 2026, from https://www.vcbacked.co/company/intellistem

Wikipedia (cite web)

{{cite web |title=Intellistem — Funding & Investors |url=https://www.vcbacked.co/company/intellistem |website=VCBacked |access-date=July 9, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 16, 2024.